3/21/2013

India's Drug Controller General plans to begin inspections of drug companies exporting to Europe to ensure that they are meeting requirements set by the World Health Organization for the manufacture of active pharmaceutical ingredients. Once a firm is found compliant with WHO regulations, it will receive a three-year certificate of good manufacturing practices. India exports more than $13 billion in pharmaceutical products annually, of which APIs account for about 40%.

Related Summaries